Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

68.0K
Overview
68.0K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

865
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
865
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

693
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
693
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

766
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
766
Antigen Presenting Cells01:22

Antigen Presenting Cells

1.7K
The immune system is a complex network of cells and molecules that protects the body from foreign invaders. T cells, a type of white blood cell, play a crucial role in this process. They recognize and attack foreign substances, such as pathogens, that enter the body.
T cells require the help of antigen-presenting cells (APCs), which process foreign antigens into smaller fragments that can be recognized by T cells. These APCs are highly specialized cells that efficiently internalize antigens...
1.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Testing the mettle of RNA methylation in T cell exhaustion.

The Journal of experimental medicine·2026
Same author

Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 Immunotherapy.

bioRxiv : the preprint server for biology·2026
Same author

CRISPR screens identify targets to rescue age-related T cell dysfunction in cancer.

bioRxiv : the preprint server for biology·2026
Same author

Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Cancer discovery·2026
Same author

Training Tomorrow's Leaders in Cancer Immunology.

Cancer immunology research·2026
Same author

In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma.

Nature·2025
Same journal

CDK2 Inhibition Exerts RB-Independent Antitumor Activity in CDK4/6 Inhibitor-Resistant HR+/HER2- Breast Cancer.

Cancer research·2026
Same journal

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same journal

Editor's Note: Heterodimerization of Insulin-like Growth Factor Receptor/Epidermal Growth Factor Receptor and Induction of Survivin Expression Counteract the Antitumor Action of Erlotinib.

Cancer research·2026
Same journal

Editor's Note: Deguelin Analogue SH-1242 Inhibits Hsp90 Activity and Exerts Potent Anticancer Efficacy with Limited Neurotoxicity.

Cancer research·2026
Same journal

Retraction: Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer.

Cancer research·2026
Same journal

Editor's Note: Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.

Cancer research·2026
See all related articles

Related Experiment Video

Updated: Jun 18, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.2K

Hyperactive Dendritc Cells Redirect Aged Antitumor Immunity.

Alex C Y Chen1,2,3,4, Debattama R Sen1,2,3,4

  • 1Krantz Family Center for Cancer Research, Massachusetts General Hospital, Boston, Massachusetts.

Cancer Research
|July 29, 2024
PubMed
Summary
This summary is machine-generated.

Aging impairs antitumor immunity by reducing CD8+ T cells and dendritic cell (DC) function. A hyperactive DC vaccine restored DC function and promoted cytolytic CD4+ T cells, offering a new strategy for cancer treatment in older adults.

More Related Videos

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.4K
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

23.0K

Related Experiment Videos

Last Updated: Jun 18, 2025

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
08:40

Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy

Published on: August 1, 2013

18.2K
Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
10:35

Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo

Published on: February 5, 2021

3.4K
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
06:09

Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes

Published on: June 22, 2016

23.0K

Area of Science:

  • Immunology
  • Oncology
  • Aging Research

Background:

  • Aging is a primary risk factor for cancer, with over 85% of diagnoses in individuals over 55.
  • Age-associated immune defects, particularly in T cells, contribute to increased cancer incidence.
  • Previous research highlighted factors like fibroblasts and immunosuppression in the aging tumor microenvironment.

Purpose of the Study:

  • To investigate age-related defects in antitumor immunity, focusing on T cell responses.
  • To explore the potential of a hyperactive dendritic cell (DC) vaccine in restoring antitumor immunity in aged individuals.
  • To identify mechanisms by which DCs influence T cell responses during aging and cancer.

Main Methods:

  • Analysis of age-related changes in CD8+ T cell levels and DC function (antigen presentation, migration).
  • Administration of a hyperactive DC vaccine in aged mouse models.
  • Evaluation of DC characteristics (IL1β production, lymph node migration) and subsequent T cell development (cytolytic CD4+ T cells, Th1 phenotype).

Main Results:

  • Aging is associated with reduced CD8+ T cells and impaired DC function, compromising antitumor immunity.
  • A hyperactive DC vaccine, enhanced with IL1β and improved migration, restored DC functions in older mice.
  • The vaccine promoted the development of cytolytic CD4+ T cells with Th1-like phenotypes, compensating for CD8+ T cell deficits.

Conclusions:

  • Hyperactive DC vaccines can overcome age-related immune defects and enhance antitumor responses in older mice.
  • Cytolytic CD4+ T cells play a crucial role in antitumor immunity and long-term tumor control in aged populations.
  • This study provides insights into DC vaccine mechanisms and highlights CD4+ T cells as potential therapeutic targets for age-related cancers.